Trending Stock News

Kdi Capital Partners Has Decreased Its Mednax (MD) Stake; 2 Analysts Covering Garrison Capital Inc. (GARS)

MEDNAX, Inc. (NYSE:MD) Logo

Among 6 analysts covering Garrison Capital (NASDAQ:GARS), 2 have Buy rating, 0 Sell and 4 Hold. Therefore 33% are positive. Garrison Capital had 16 analyst reports since August 5, 2015 according to SRatingsIntel. Maxim Group maintained Garrison Capital Inc. (NASDAQ:GARS) rating on Thursday, August 10. Maxim Group has “Buy” rating and $1100 target. The rating was maintained by Maxim Group with “Buy” on Monday, November 9. The stock of Garrison Capital Inc. (NASDAQ:GARS) earned “Buy” rating by National Securities on Wednesday, August 5. The firm earned “Market Perform” rating on Friday, May 12 by Oppenheimer. The stock of Garrison Capital Inc. (NASDAQ:GARS) has “Buy” rating given on Wednesday, August 5 by Zacks. The company was downgraded on Friday, November 6 by Ladenburg Thalmann. The stock has “Hold” rating by Oppenheimer on Thursday, August 10. Maxim Group maintained the stock with “Buy” rating in Monday, August 10 report. The firm earned “Buy” rating on Friday, March 9 by Maxim Group. Wunderlich downgraded Garrison Capital Inc. (NASDAQ:GARS) rating on Thursday, March 16. Wunderlich has “Hold” rating and $10 target. See Garrison Capital Inc. (NASDAQ:GARS) latest ratings:

09/03/2018 Broker: Maxim Group Rating: Buy New Target: $11.0 Maintain
09/11/2017 Broker: Robert W. Baird Rating: Hold New Target: $9.0 Maintain
09/11/2017 Broker: Maxim Group Rating: Buy New Target: $11.0 Maintain

Kdi Capital Partners Llc decreased Mednax Inc (MD) stake by 51.09% reported in 2017Q4 SEC filing. Kdi Capital Partners Llc sold 82,675 shares as Mednax Inc (MD)’s stock rose 2.30%. The Kdi Capital Partners Llc holds 79,147 shares with $4.23 million value, down from 161,822 last quarter. Mednax Inc now has $4.93B valuation. The stock decreased 1.31% or $0.7 during the last trading session, reaching $52.85. About 683,524 shares traded. MEDNAX, Inc. (NYSE:MD) has declined 21.42% since April 13, 2017 and is downtrending. It has underperformed by 32.97% the S&P500.

The stock increased 0.73% or $0.06 during the last trading session, reaching $8.27. About 4,717 shares traded. Garrison Capital Inc. (NASDAQ:GARS) has declined 14.99% since April 13, 2017 and is downtrending. It has underperformed by 26.54% the S&P500.

Investors sentiment decreased to 1.17 in 2017 Q4. Its down 0.10, from 1.27 in 2017Q3. It dived, as 4 investors sold Garrison Capital Inc. shares while 8 reduced holdings. 4 funds opened positions while 10 raised stakes. 3.57 million shares or 8.15% more from 3.30 million shares in 2017Q3 were reported. Tower Rech Capital Limited Liability (Trc) reported 0% in Garrison Capital Inc. (NASDAQ:GARS). Janney Montgomery Scott Ltd Limited Liability Company reported 17,182 shares or 0% of all its holdings. Wells Fargo & Mn has invested 0% in Garrison Capital Inc. (NASDAQ:GARS). Stephens Ar holds 0.01% or 24,721 shares in its portfolio. Acadian Asset Limited Liability owns 5,721 shares. Millennium Mngmt Ltd Llc invested in 24,735 shares or 0% of the stock. 2,700 are held by Royal Bancorp Of Canada. D E Shaw And Inc reported 10,359 shares. Blackrock reported 108,414 shares or 0% of all its holdings. Drw Limited Liability Company owns 434,262 shares or 0.37% of their US portfolio. Oppenheimer And Inc owns 35,873 shares or 0.01% of their US portfolio. 1.00 million were reported by Caxton. The Pennsylvania-based Hudock Cap Group Inc Limited Liability Company has invested 0% in Garrison Capital Inc. (NASDAQ:GARS). 1.06M are owned by Rivernorth Mngmt Ltd Liability. Morgan Stanley has invested 0% in Garrison Capital Inc. (NASDAQ:GARS).

Among 19 analysts covering MEDNAX (NYSE:MD), 5 have Buy rating, 1 Sell and 13 Hold. Therefore 26% are positive. MEDNAX had 51 analyst reports since July 31, 2015 according to SRatingsIntel. Dougherty & Company maintained MEDNAX, Inc. (NYSE:MD) rating on Friday, July 31. Dougherty & Company has “Buy” rating and $90 target. The stock has “Hold” rating by SunTrust on Wednesday, December 20. The stock of MEDNAX, Inc. (NYSE:MD) has “Hold” rating given on Tuesday, April 11 by Jefferies. Jefferies maintained MEDNAX, Inc. (NYSE:MD) on Thursday, August 31 with “Hold” rating. The firm has “Buy” rating by KeyBanc Capital Markets given on Monday, December 4. The company was maintained on Thursday, February 8 by Robert W. Baird. As per Thursday, June 22, the company rating was upgraded by Stephens. As per Thursday, February 8, the company rating was maintained by Stephens. The stock of MEDNAX, Inc. (NYSE:MD) earned “Hold” rating by Jefferies on Monday, June 5. The firm has “Hold” rating by SunTrust given on Thursday, February 8.

Analysts await MEDNAX, Inc. (NYSE:MD) to report earnings on April, 19. They expect $0.81 earnings per share, up 15.71% or $0.11 from last year’s $0.7 per share. MD’s profit will be $75.61M for 16.31 P/E if the $0.81 EPS becomes a reality. After $0.82 actual earnings per share reported by MEDNAX, Inc. for the previous quarter, Wall Street now forecasts -1.22% negative EPS growth.

Kdi Capital Partners Llc increased Merck & Co Inc (NYSE:MRK) stake by 18,693 shares to 22,497 valued at $1.27 million in 2017Q4. It also upped Walgreens Boots Alliance Inc (NYSE:WMT) stake by 8,700 shares and now owns 28,000 shares. Ishares Tr (IJH) was raised too.

Garrison Capital Inc. (NASDAQ:GARS) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *